Where does Tom Thomas work?

Tom Thomas is Principal at Newpath Partners.

What check size does Tom Thomas write?

Tom Thomas typically writes checks of $500K – $40M.

Where did Tom Thomas go to school?

Tom Thomas studied at Harvard Medical School (Postdoctoral Fellowship, Molecular Pathology & Oncology); Cedars-Sinai Medical Center (Ph.D., Biomedical Science and Translational Medicine); UCLA (B.S., Physiological Sciences).

Tom Thomas

Investor

Principal at Newpath Partners · Therapeutics Advisory Panel, UCLA Innovation Fund at UCLA Ventures

Boston, Massachusetts

Writes $500K – $40M checks · typically $15M

Find your path to Tom

513 people in our graph share verified history with Tom — schools, employers, funds. One of them is your warm intro.

Paul FieldingunlockedTom: together at UCLA (2008)

Tom: together at UCLA

×3Tom: together at Flagship Pioneering

Tom: together at Cedars-Sinai

About

Tom Thomas is an investor at Newpath Partners and serves as a board director at CREATE Medicines. He has held positions at RA Capital Management focusing on oncology investments and co-founded Flagship Labs 89, where he served as head of translational biology. His background includes cancer biology research with expertise in patient-derived cell models, organoid systems, and cancer metabolomics.

Experience

CREATE MedicinesBoard Directorcurrent2026 — present
Cleveland ClinicExternal Advisory Councilcurrent2026 — present
Newpath PartnersInvestor, Principalcurrent2024 — present
UCLA Technology Development GroupTherapeutics Advisory Panel, UCLA Innovation Fundcurrent2025 — present
Magnet BiomedicineBoard Observercurrent2024 — present
Exo TherapeuticsBoard Directorcurrent2024 — present
Kisbee TherapeuticsBoard Observer2024 — 2025
Sera Medicines, LLCFounding Team2023 — 2024
RA Capital Management, L.P.Healthcare Associate2022 — 2024Boston, Massachusetts, United States
Prologue MedicinesFounding Team2021 — 2022
Flagship PioneeringAssociate2020 — 2022Cambridge, Massachusetts, United States
Flagship PioneeringFellow2020Cambridge, Massachusetts, United States
Emmanuel College (Boston)Adjunct Faculty of Biology2018 — 2020Greater Boston Area
Harvard Medical SchoolResearch Fellow2017 — 2020Boston, Massachusetts, United States
Cedars-SinaiPh.D Candidate, Cancer Biology2013 — 2017
University of California, Los AngelesResearch Associate2008 — 2011Los Angeles, California, United States
Scripps ResearchResearch Intern2005 — 2006

Skills & more

Board GovernanceCorporate StrategyProject Portfolio ManagementStart-up VenturesStart-up LeadershipEarly Stage InvestmentNew Venture DevelopmentCell Culture12Molecular Biology9Genetics4Clinical Research7Research5

+11 more

BiochemistryCancer ResearchCancerTumor ImmunologyStem Cell ResearchCancer Stem CellsTissue CultureMetabolismMicrosoft OfficeHealthcare InvestingCell Biology

Languages English · Malayalam · Spanish

Health Care Economics — Harvard Business School
Healthcare Innovation & Commercialization — Harvard Medical School

From Tom's professional profile.

Colleagues at Newpath Partners

Daniel Yadegar

Co-Founder and Chief Medical Officer at Newpath Partners

Thomas Cahill

Managing Partner at Newpath Partners

Frequently asked questions

Who is Tom Thomas?: Tom Thomas is an investor at Newpath Partners and serves as a board director at CREATE Medicines. He has held positions at RA Capital Management focusing on oncology investments and co-founded Flagship Labs 89, where he served as head of translational biology. His background includes cancer biology research with expertise in patient-derived cell models, organoid systems, and cancer metabolomics.
Where does Tom Thomas work?: Tom Thomas is Principal at Newpath Partners.
What check size does Tom Thomas write?: Tom Thomas typically writes checks of $500K – $40M.
Where did Tom Thomas go to school?: Tom Thomas studied at Harvard Medical School (Postdoctoral Fellowship, Molecular Pathology & Oncology); Cedars-Sinai Medical Center (Ph.D., Biomedical Science and Translational Medicine); UCLA (B.S., Physiological Sciences).

Same school

Also attended Harvard Medical School245

Niko BonatsosFounder and Managing Partner of Verdict Anthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 239 more

Also attended UCLA833

Ben HorowitzCo-founder & General Partner at Andreessen Horowitz Kirsten GreenFounder and Managing Partner at Forerunner Ventures Vlad TenevCo-founder & CEO of Robinhood Ryan KingCo-founder of Chime Paul FieldingFinance & Operations at General Catalyst Melody MaExecutive Assistant and Lead Receptionist at Trinity Ventures

+ 827 more

Shared employers

Also worked at Exo Therapeutics6

Sarah KeaneExecutive Assistant at The Engine Ventures Dylan MorrisManaging Director at Insight Partners Nagesh MahanthappaExecutive Officer, Director at Scholar Rock Thilo SchroederGeneral Partner at Nextech Partners SCSp Thilo SchroederGeneral Partner at Nextech SCSP Thilo SchroederGeneral Partner at Nextech Carry SCSP

Also worked at Flagship Pioneering88

Anika GuptaInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship Pioneering Cassidy BlundellPartner at Mission Biocapital David KoleskyPrincipal at MPM BioImpact Diana BernsteinDirector at Northpond Ventures Inca ComanVenture Partner at ARCH Venture Partners

+ 82 more

Also worked at Emmanuel College (Boston)3

Megan NobleExecutive Assistant & Office Coordinator at Lerer Hippeau Emily JenkinsOperations Manager at Founder Collective Adam MartelFounder at Givzey

Also worked at Harvard Medical School273

Logan HilleLife Sciences Analyst at CincyTech Ankit GuptaGeneral Partner at Y Combinator David MollerInvestor at Third Rock Ventures Samuel ArbesmanVenture Partner at Lux Capital Zach CollinsPartner at Mission Biocapital Alexi Nazem, MDGeneral Partner at AlleyCorp

+ 267 more